Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety and Feasibility of the DragonFire Transcatheter Radiofrequency Myocardial Ablation System

NCT06211595 is registered in ClinicalTrials.gov with Hangzhou Valgen Medtech Co., Ltd as lead sponsor.

NCT NCT06211595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety and Feasibility of the DragonFire Transcatheter Radiofrequency Myocardial Ablation System
Lead sponsor
Hangzhou Valgen Medtech Co., Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
October 13, 2022
Completion date
November 30, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive hypertrophic cardiomyopathy